NCT00461604View on ClinicalTrials.gov

High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Patients With Persistent Objectified Gastroesophageal Reflux and Reflux-Associated Symptoms Despite PPI-Therapy With 40mg Esomeprazole
Trial Locations (1)

81675

Technical University of Munich, Munich

All Listed Sponsors
lead

Technical University of Munich

OTHER

NCT00461604 - High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease | Biotech Hunter | Biotech Hunter